The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2011-12-01
|
| Series: | Oncology Reviews |
| Assuntos: | |
| Acceso en liña: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|